Biotechnology News

SAN DIEGO, Oct. 19, 2012 (GLOBE NEWSWIRE) -- IDWeek 2012 -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} TGFTX3 PROGRAM (REV-ERB): SIGNIFICANT PROGRESS IN...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PROGRAMME REV-ERB (TGFTX3) : AVANCEES SIGNIFICATIVES...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GENFIT: CONVERSION INTO SHARES OF THE REMAINING BOND...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} GENFIT : CONVERSION EN ACTIONS DES DERNIERES...

CAMBRIDGE, Mass., Oct. 19, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...

ROCKVILLE, Md., Oct. 19, 2012 (GLOBE NEWSWIRE) -- Nabi today announced that, if the proposed business combination transaction between Nabi Biopharmaceuticals (Nasdaq:NABI) and Biota Holdings Limited...

Læs hele meddelelsen i pdf format....

Read the full announcement in PDF format....

Lund den 19 oktober, 2012 - Active Biotech (NASDAQ OMX NORDIC: ACTI) meddelar idag att samarbetspartnern Ipsen (Euronext: IPN; ADR: IPSEY, läs pressmeddelandet här) kommer att inleda en ny fas...